Similarly to our previous study of Dnmt3a+/− mice, our data identify Dnmt3b as a haploinsufficient tumor suppressor in T-cell lymphomas (TCL) and CLL (36). This evidence concerns the gene DNMT3B and B-cell chronic lymphocytic leukemia.